http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-950528-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bba842fc4d37dfcaced1b55bc0c91c7c
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D457-04
filingDate 1961-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db17699cad3aa74fb10fc6ffab3f9635
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a95a5aaf5b25c8696a008bf469be5209
publicationDate 1964-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-950528-A
titleOfInvention Improvements in or relating to lysergic acid derivatives
abstract The invention comprises lysergic acid derivatives of general formula: <FORM:0950528/C2/1> in which R1 is a C1-4 alkyl radical, each of R2 and R3 is a hydrogen atom, a C1-4 alkyl or hydroxyalkyl radical or a monocyclic aryl radical, and \sG signifies the radical -CH=C< or <FORM:0950528/C2/2> ; and their acid addition salts; and a process for preparing these compounds in which the corresponding lysergic acid azide is heated to form the isocyanate, which is reacted with an amino compound <FORM:0950528/C2/3> , and, if desired, salification is effected with an organic or inorganic acid. The azides are prepared from the corresponding lysergic and dihydrolysergic acid hydrazides using hydrochloric acid and sodium nitrite solution, and the hydrazides in turn are prepared by heating 1-substituted derivatives of natural ergot alkaloids, or their dihydro derivatives, with anhydrous hydrazine. In the examples the amines used in the preparation of the carbamides are anilene, diethylamine and (+)-butaolamine -(21). Pharmaceutical compositions, having sedative, serotonin inhibiting and/or blood pressure lowering action, comprise the compounds of the invention together with inert carriers. Specification 948,203 is referred to.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4692452-A
priorityDate 1960-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8021
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410506103
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5202
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID105034
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419581185
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559500
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419549034
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449323691
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23668193
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9321
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559527
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416043568
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450649535
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419520471
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5493302
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID622987
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID33558
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6717

Total number of triples: 33.